These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9049223

  • 1. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
    Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, Ohnishi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M.
    Hepatology; 1997 Mar; 25(3):705-12. PubMed ID: 9049223
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T lymphocyte responses in hepatitis C virus infection.
    Imawari M, Kita H, Moriyama T, Kaneko T, Hiroishi K.
    Princess Takamatsu Symp; 1995 Mar; 25():221-5. PubMed ID: 8875627
    [Abstract] [Full Text] [Related]

  • 3. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ, Wang WL, Wang T.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
    [Abstract] [Full Text] [Related]

  • 4. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A.
    J Immunol; 1999 Jan 15; 162(2):1156-64. PubMed ID: 9916747
    [Abstract] [Full Text] [Related]

  • 5. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J, Ahlén G, Kaul A, Frelin L, Alheim M, Barnfield C, Liljeström P, Weiland O, Milich DR, Bartenschlager R, Sällberg M.
    Gut; 2006 Feb 15; 55(2):266-74. PubMed ID: 16105887
    [Abstract] [Full Text] [Related]

  • 6. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 7. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein.
    Kita H, Moriyama T, Kaneko T, Harase I, Nomura M, Miura H, Nakamura I, Yazaki Y, Imawari M.
    Hepatology; 1993 Nov 15; 18(5):1039-44. PubMed ID: 7693568
    [Abstract] [Full Text] [Related]

  • 8. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.
    Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JY.
    J Immunol; 1997 Feb 01; 158(3):1473-81. PubMed ID: 9013994
    [Abstract] [Full Text] [Related]

  • 9. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.
    J Med Virol; 2004 Apr 01; 72(4):575-85. PubMed ID: 14981760
    [Abstract] [Full Text] [Related]

  • 10. Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.
    Weiner AJ, Erickson AL, Kansopon J, Crawford K, Muchmore E, Houghton M, Walker CM.
    Princess Takamatsu Symp; 1995 Apr 01; 25():227-35. PubMed ID: 8875628
    [Abstract] [Full Text] [Related]

  • 11. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
    Fan CL, Chen HS, Li RB, Wang SX, Cong X, Fei R, Jiang D, Wang Y, Wei L.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb 01; 12(2):67-71. PubMed ID: 14980100
    [Abstract] [Full Text] [Related]

  • 12. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.
    Hepatology; 2001 Jun 01; 33(6):1533-43. PubMed ID: 11391544
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
    Ballardini G, Groff P, Pontisso P, Giostra F, Francesconi R, Lenzi M, Zauli D, Alberti A, Bianchi FB.
    J Clin Invest; 1995 May 01; 95(5):2067-75. PubMed ID: 7738174
    [Abstract] [Full Text] [Related]

  • 14. Inefficient recognition of autologous viral sequences by intrahepatic hepatitis C virus-specific cytotoxic T lymphocytes in chronically infected subjects.
    Giuggio VM, Bonkovsky HL, Smith J, Rothman AL.
    Virology; 1998 Nov 10; 251(1):132-40. PubMed ID: 9813209
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA, Oka S, Takiguchi M.
    Tissue Antigens; 2005 Oct 10; 66(4):305-13. PubMed ID: 16185326
    [Abstract] [Full Text] [Related]

  • 18. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh K, Yamada A.
    Cell Immunol; 2006 May 10; 241(1):38-46. PubMed ID: 16963008
    [Abstract] [Full Text] [Related]

  • 19. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 10; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 20. Influenza virus CTL epitopes, remarkably conserved and remarkably variable.
    Rimmelzwaan GF, Kreijtz JH, Bodewes R, Fouchier RA, Osterhaus AD.
    Vaccine; 2009 Oct 23; 27(45):6363-5. PubMed ID: 19840674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.